...股收益》第十三条的规定不符；未将新股申购所得列入非经常性损益，现更正如下：一、原报告及摘要（一）主要会计数据和财务指标单位：（人民币）元本报告期末上年度期末总资产1,729,899,773.071,206,906,538.93所有者权益（或股...
医药产业医药经济；资本&财经...元）项目金额利润总额139,234,824.92净利润67,313,918.95扣除非经常性损益后的净利润（注）67,341,194.59主营业务利润622,512,917.76其它业务利润21,713,590.46营业利润139,460,177.86投资收益286,465.04补贴收入1,902,989.00营业外收支净额-2,414,806.98经...
医药产业医药经济；资本&财经...币项目金额利润总额-74,365,742.10净利润-75,283,213.11扣除非经常性损益后的净利润-77,529,689.82主营业务利润58,599,362.42其他业务利润2,541,154.68营业利润-70,474,454.93投资收益2,172,519.82补贴收入321,000.00营业外收支净额-6,384,806.99经营活动产...
医药产业医药经济；资本&财经...民币项目金额利润总额108,724,776.95净利润72,646,313.02扣除非经常性损益后的净利润70,449,821.60主营业务利润180,159,433.31其他业务利润营业利润108,852,550.95投资收益补贴收入营业外收支净额-127,774.00经营活动产生的现金流量净额133,131,863...
医药产业医药经济；资本&财经....8550,321,043.2247,851,604.33181.71%归属于上市公司股东的扣除非经常性损益的净利润89,860,208.6946,864,917.3444,395,478.45102.41%经营活动产生的现金流量净额88,363,104.9157,552,511.5860,782,511.5845.38%总资产586,634,880.36461,606,190.65462,609,966.7626.81%所有者...
医药产业医药经济；资本&财经...-138,965,163.81-134,831,278.69166.74归属于上市公司股东的扣除非经常性损益的净利润59,206,848.42-133,998,349.85-129,864,464.73144.18基本每股收益0.513-1.152-1.118144.53稀释每股收益0.513-1.152-1.118144.53扣除非经常性损益后的基本每股收益0.328-1.112-1.07712...
医药产业医药经济；资本&财经...民币项目金额利润总额10,504,257.85净利润13,395,072.57扣除非经常性损益后的净利润13,646,970.45主营业务利润112,878,932.83其他业务利润2,497,851.39营业利润13,375,018.71投资收益-1,092,747.66补贴收入营业外收支净额-1,778,013.20经营活动产生的现...
医药产业医药经济；资本&财经...16.5378,427,126.9376,938,603.4323.17归属于上市公司股东的扣除非经常性损益的净利润92,215,132.2881,489,472.5080,000,949.0013.16基本每股收益0.330.270.2622.22稀释每股收益0.330.270.2622.22扣除非经常性损益后的基本每股收益0.310.280.2710.71全面摊薄净资...
医药产业医药经济；资本&财经...5,535,737.3915,155,207.731.46基本每股收益(元)0.040.11-15.38扣除非经常性损益后基本每股收益(元)0.020.0912.50稀释每股收益(元)0.040.11-15.38净资产收益率(%)0.922.52减少0.02个百分点扣除非经常性损益后的净资产收益率(%)0.412.01增加0.54个百分点...
医药产业医药经济；资本&财经...年比上年增减（％）2003年每股收益0.360.65-44.62%0.82扣除非经常性损益的每股收益0.33---净资产收益率8.10%10.21%减少了2.11个百分点21.58%扣除非经常性损益的净利润为基础计算的净资产收益率7.44%8.77%减少了1.33个百分点20.24%每股经营活...
医药产业医药经济；资本&财经